Abstract
Chronic bullous disease of childhood (CBDC) also known as linear IgA disease (LAD), although rare, is the most common acquired immunobullous disease of childhood. It shares the same immunohistochemical features as LAD in adults characterized by the deposition of IgA along the basement membrane zone which causes a subepidermal blister. The distinct clinical presentation of CBDC distinguishes it from other entities and will be reviewed in this chapter. The etiology of CBDC is most often idiopathic. Drug-induced linear IgA especially from vancomycin is more common in adults than children and may respond to stopping the medication culprit. Standard of care is treatment with dapsone, but other treatments have been used with varying success. Although mucous membrane involvement and scarring may occur in a subset of patients, the majority of children with this condition have a good prognosis, with remission expected within months to a few years.
The authors have no funding support to disclose.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sweren RJ, Burnett JW. Benign chronic bullous dermatosis of childhood: a review. Cutis. 1982;29(4):350–2, 356–7.
Grant PW. Juvenile dermatitis herpetiformis. Trans St Johns Hosp Dermatol Soc. 1968;54(2):128–36.
Kim R, Winkelmann RK. Dermatitis herpetiformis in children. Relationship to bullous pemphigoid. Arch Dermatol. 1961;83:895–902.
Jordon RE, Bean SF, Triftshauser CT, et al. Childhood bullous dermatitis herpetiformis. Negative immunofluorescent tests. Arch Dermatol. 1970;101(6):629–34.
Wojnarowska F. Chronic bullous disease of childhood. Semin Dermatol. 1988;7(1):58–65.
Wojnarowska F, Marsden RA, Bhogal B, et al. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol. 1988;19(5 Pt 1):792–805.
Hruza LL, Mallory SB, Fitzgibbons J, et al. Linear IgA bullous dermatosis in a neonate. Pediatr Dermatol. 1993;10(2):171–6.
Kishida Y, Kameyama J, Nei M, et al. Linear IgA bullous dermatosis of neonatal onset: case report and review of the literature. Acta Paediatr. 2004;93(6):850–2.
Salud CM, Nicolas ME. Chronic bullous disease of childhood and pneumonia in a neonate with VATERL association and hypoplastic paranasal sinuses. J Am Acad Dermatol. 2010;62(5):895–6.
Rogers M, Bartlett B, Walder B, et al. Chronic bullous disease of childhood—aspects of management. Australas J Dermatol. 1982;23(2):62–9.
Coleman H, Shrubb VA. Chronic bullous disease of childhood- another cause for potential misdiagnosis of sexual abuse? Br J Gen Pract. 1997;47(421):507–8.
Patricio P, Ferreira C, Gomes MM, et al. Autoimmune bullous dermatoses: a review. Ann N Y Acad Sci. 2009;1173:203–10.
Sansaricq F, Stein SL, Petronic-Rosic V. Autoimmune bullous diseases in childhood. Clin Dermatol. 2012;30(1):114–27.
Burge S, Wojnarowska F, Marsden A. Chronic bullous dermatosis of childhood persisting into adulthood. Pediatr Dermatol. 1988;5(4):246–9.
Collier PM, Wojnarowska F, Millard PR. Variation in the deposition of the antibodies at different anatomical sites in linear IgA disease of adults and chronic bullous disease of childhood. Br J Dermatol. 1992;127(5):482–4.
Wojnarowska F, Collier PM, Allen J, et al. The localization of the target antigens and antibodies in linear IgA disease is heterogeneous, and dependent on the methods used. Br J Dermatol. 1995;132(5):750–7.
Wojnarowska F, Bhogal BS, Black MM. Chronic bullous disease of childhood and linear IgA disease of adults are IgA1-mediated diseases. Br J Dermatol. 1994;131(2):201–4.
Willsteed E, Bhogal BS, Black MM, et al. Use of 1M NaCl split skin in the indirect immunofluorescence of the linear IgA bullous dermatoses. J Cutan Pathol. 1990;17(3):144–8.
Powell J, Kirtschig G, Allen J, et al. Mixed immunobullous disease of childhood: a good response to antimicrobials. Br J Dermatol. 2001;144(4):769–74.
Collier PM, Wojnarowska F, Welsh K, et al. Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression. Br J Dermatol. 1999;141(5):867–75.
Salmhofer W, Soyer HP, Wolf P, et al. UV light-induced linear IgA dermatosis. J Am Acad Dermatol. 2004;50(1):109–15.
Schumann H, Baetge J, Tasanen K, et al. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol. 2000;156(2):685–95.
Marinkovich MP, Taylor TB, Keene DR, et al. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol. 1996;106(4):734–8.
Zone JJ, Taylor TB, Kadunce DP, et al. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest. 1990;85(3):812–20.
Zone JJ, Taylor TB, Kadunce DP, et al. IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein. J Invest Dermatol. 1996;106(6):1277–80.
Ghohestani RF, Nicolas JF, Kanitakis J, et al. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens. J Invest Dermatol. 1997;108(6):854–8.
Hashimoto T, Ishiko A, Shimizu H, et al. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. Br J Dermatol. 1996;134(2):336–9.
Allen J, Zhou S, Wakelin SH, et al. Linear IgA disease: a report of two dermal binding sera which recognize a pepsin-sensitive epitope (?NC-1 domain) of collagen type VII. Br J Dermatol. 1997;137(4):526–33.
Yamane Y, Sato H, Higashi K, et al. Linear immunoglobulin A (IgA) bullous dermatosis of childhood: identification of the target antigens and study of the cellular sources. Br J Dermatol. 1996;135(5):785–90.
Zhou S, Ferguson DJ, Allen J, et al. The localization of target antigens and autoantibodies in linear IgA disease is variable: correlation of immunogold electron microscopy and immunoblotting. Br J Dermatol. 1998;139(4):591–7.
Dmochowski M, Hashimoto T, Bhogal BS, et al. Immunoblotting studies of linear IgA disease. J Dermatol Sci. 1993;6(3):194–200.
Wojnarowska F, Whitehead P, Leigh IM, et al. Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults. Br J Dermatol. 1991;124(2):157–62.
Zambruno G, Manca V, Kanitakis J, et al. Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol. 1994;31(5 Pt 2):884–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Geller, L., Mintz, E.M., Morel, K.D. (2015). Clinical Features and Pathogenesis of Chronic Bullous Disease of Childhood. In: Murrell, D. (eds) Blistering Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45698-9_34
Download citation
DOI: https://doi.org/10.1007/978-3-662-45698-9_34
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45697-2
Online ISBN: 978-3-662-45698-9
eBook Packages: MedicineMedicine (R0)